Validation of ACS NSQIP Risk Calculator for Predicting Complications After Thoracic Surgery at University Hospital Basel
Validation of the ACS NSQIP Risk Calculator as Predictive Tool for Complications After Thoracic Surgery in Consecutive Series of Patients Operated at the Department of Thoracic Surgery University Hospital Basel
1 other identifier
observational
300
1 country
1
Brief Summary
This single-center retrospective research project aims to evaluate whether and what is the significance of the National Surgical Quality Improvement Program of the American College of Surgeons (ACS NSQIP) risk score in thoracic surgery at the University Hospital Basel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2023
CompletedFirst Submitted
Initial submission to the registry
June 21, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedJuly 3, 2024
June 1, 2024
10 months
June 21, 2024
June 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Suitability of the ACS NSQIP risk calculator
To evaluate the suitability of the National Surgical Quality Improvement Program of the American College of Surgeons (ACS NSQIP) risk calculator for thoracic surgery, the ACS NSQIP risk score is compared to actual complications. ACS NSQIP risk score is a tool used to predict the likelihood of postoperative complications and mortality in surgical patients. It is calculated based on a range of preoperative variables, including patient demographics, comorbidities, and the type of surgery being performed. The values of the ACS NSQIP risk score can range from 0 to 100, with higher scores indicating a higher risk of complications and a worse expected outcome.
Up to 30 days after surgery
Eligibility Criteria
A consecutive series of cases of patients who signed the general research consent of the University Hospital Basel and have undergone a thoracic intervention at the University Hospital Basel between 01.05.2021 to 01.03.2022.
You may qualify if:
- Patients with signed general research consent
- Patients who underwent surgery in our department for the period from 01.05.2021 to 01.03.2022
- Patients with preoperative ACS NSQIP Risk score
You may not qualify if:
- Patients who have clearly stated that they would not agree in providing their clinical data for scientific purposes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Thoracic Surgery, University Hospital of Basel
Basel, 4031, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Nikolay Tsvetkov, MD
Department of Thoracic Surgery, University Hospital of Basel
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2024
First Posted
July 3, 2024
Study Start
May 1, 2021
Primary Completion
March 1, 2022
Study Completion
August 31, 2023
Last Updated
July 3, 2024
Record last verified: 2024-06